LON:GNOG Holdings Information

LON:GNOG is an equity ETF with a total of 49 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 7.06%, Avidity Biosciences at 5.31%, CRISPR Therapeutics AG at 5.02%, Guardant Health at 4.90%, and Illumina at 4.75%.

Total Holdings

Top 10 Percentage

46.60%

Asset Class

Equity

ETF Category

Theme

Assets

7.82M

PE Ratio

n/a

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ALNY	Alnylam Pharmaceuticals, Inc.	7.06%	1,598
2	RNA	Avidity Biosciences, Inc.	5.31%	12,586
3	CRSP	CRISPR Therapeutics AG	5.02%	10,060
4	GH	Guardant Health, Inc.	4.90%	8,463
5	ILMN	Illumina, Inc.	4.75%	5,064
6	QGEN	Qiagen N.V.	4.24%	9,126
7	NTRA	Natera, Inc.	3.98%	2,600
8	TECH	Bio-Techne Corporation	3.93%	7,697
9	LEGN	Legend Biotech Corporation	3.78%	11,258
10	MRNA	Moderna, Inc.	3.61%	14,548
11	WGS	GeneDx Holdings Corp.	3.59%	3,146
12	BNTX	BioNTech SE	3.54%	3,380
13	BMRN	BioMarin Pharmaceutical Inc.	3.42%	6,233
14	HKG: 1548	Genscript Biotech Corporation	3.12%	141,698
15	VRTX	Vertex Pharmaceuticals Incorporated	2.95%	786
16	RARE	Ultragenyx Pharmaceutical Inc.	2.91%	10,410
17	ARWR	Arrowhead Pharmaceuticals, Inc.	2.83%	14,447
18	VCYT	Veracyte, Inc.	2.70%	9,721
19	LON: AZN	AstraZeneca PLC	2.16%	1,409
20	A	Agilent Technologies, Inc.	2.03%	1,837
21	GILD	Gilead Sciences, Inc.	1.99%	1,815
22	BMY	Bristol-Myers Squibb Company	1.82%	3,977
23	TWST	Twist Bioscience Corporation	1.78%	7,128
24	BEAM	Beam Therapeutics Inc.	1.64%	10,865
25	TXG	10x Genomics, Inc.	1.60%	12,899

As of Aug 21, 2025

Showing 25 of 49

Subscribe to see the full list